SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
SC 13D/A | An amendment to a SC 13D filing |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
SC 13G/A | An amendment to the SC 13G filing |
View HTML |
Displaying 951 - 960 of 970 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.